MarketInOut Stock Screener Log In | Sign Up

LTR Pharma Ltd

Healthcare • Biotechnology • Quote as of 10/28/2026 15:56
LTR Pharma Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
Market Capitalization81.11 mln
Float107 mln
Earnings Date03/04/2027

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-2.65
Likely reliable

Relative Strength

33 / 100
Underperforming

Pre-Tax Margin

-7,431%
Severely loss-making

ROE

-50.09
Deeply negative

Altman Z-Score

84.31
Exceptional

Business Description

Founded in Brisbane in 2020, LTR Pharma is an Australian drug development company working to bring a new treatment option to men with erectile dysfunction. Rather than a traditional pill, the company's main product, SPONTAN, delivers medication through a nasal spray combining vardenafil HCL with an established class of ED medicine. The goal is to offer a faster and more convenient alternative to what is currently available on the market.

Key Fundamentals

EPS-0.08
ROE-50.09
RPS0.00
ROIC-1,794
ROA-48.99
EBITDA, mln-13.66
EV / EBITDA-4.96
EV / EBIT-4.96
Revenue, mln0.18
EV / Revenue368

Quote Details

Last 0.44
Change 0 (0%)
Open 0.425
Volume 49,236
Turnover 21,664
Average Volume 173,407

Financial Ratios

Pre-Tax Profit Margin-7,431
Current Ratio34.36
Price / Book4.32
Price / Tangible Book4.36
Price / Sales480

Financial Strength

Altman Z-Score84.31
Piotroski F-Score 3 / 9
Beneish M-Score-2.65

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -9.28% 12 / 100   
1 Month -8.33% 37 / 100   
2 Months -10.2% 34 / 100   
6 Months -3.3% 52 / 100   
1 Year -12% 45 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog